Fig. 1
The first patient’s PET/MRI at 12-month anti-TB medication therapy (b) revealed the decreased bone marrow edema, pre- and intra-vertebral abscesses, paraspinal soft tissues, and SUVmax (from 9.75 to 1.83) on L2–3 compared with PET/MRI at 4-month anti-TB medication therapy (a). There was no relapse during the one-year follow-up period after discontinuation of treatment